210 related articles for article (PubMed ID: 23897826)
1. Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4.
Ma S; Shukla V; Fang L; Gould KA; Joshi SS; Lu R
J Biol Chem; 2013 Sep; 288(37):26430-40. PubMed ID: 23897826
[TBL] [Abstract][Full Text] [Related]
2. A role for IRF4 in the development of CLL.
Shukla V; Ma S; Hardy RR; Joshi SS; Lu R
Blood; 2013 Oct; 122(16):2848-55. PubMed ID: 23926303
[TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia.
Shukla V; Shukla A; Joshi SS; Lu R
Oncotarget; 2016 Jul; 7(27):41081-41094. PubMed ID: 27232759
[TBL] [Abstract][Full Text] [Related]
4. Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model.
Scaglione BJ; Salerno E; Balan M; Coffman F; Landgraf P; Abbasi F; Kotenko S; Marti GE; Raveche ES
Br J Haematol; 2007 Dec; 139(5):645-57. PubMed ID: 17941951
[TBL] [Abstract][Full Text] [Related]
5. The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia.
Salerno E; Yuan Y; Scaglione BJ; Marti G; Jankovic A; Mazzella F; Laurindo MF; Despres D; Baskar S; Rader C; Raveche E
Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S98-109. PubMed ID: 20839343
[TBL] [Abstract][Full Text] [Related]
6. The NZB mouse as a model for chronic lymphocytic leukemia.
Phillips JA; Mehta K; Fernandez C; Raveché ES
Cancer Res; 1992 Jan; 52(2):437-43. PubMed ID: 1370214
[TBL] [Abstract][Full Text] [Related]
7. B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.
Asslaber D; Qi Y; Maeding N; Steiner M; Denk U; Höpner JP; Hartmann TN; Zaborsky N; Greil R; Egle A
Blood; 2019 Nov; 134(20):1717-1729. PubMed ID: 31537531
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model.
Rebolleda N; Losada-Fernandez I; Perez-Chacon G; Castejon R; Rosado S; Morado M; Vallejo-Cremades MT; Martinez A; Vargas-Nuñez JA; Perez-Aciego P
PLoS One; 2016; 11(4):e0154159. PubMed ID: 27101369
[TBL] [Abstract][Full Text] [Related]
9. Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice.
Raveche ES; Salerno E; Scaglione BJ; Manohar V; Abbasi F; Lin YC; Fredrickson T; Landgraf P; Ramachandra S; Huppi K; Toro JR; Zenger VE; Metcalf RA; Marti GE
Blood; 2007 Jun; 109(12):5079-86. PubMed ID: 17351108
[TBL] [Abstract][Full Text] [Related]
10. IRF4 mutations in chronic lymphocytic leukemia.
Havelange V; Pekarsky Y; Nakamura T; Palamarchuk A; Alder H; Rassenti L; Kipps T; Croce CM
Blood; 2011 Sep; 118(10):2827-9. PubMed ID: 21791429
[TBL] [Abstract][Full Text] [Related]
11. IRF4(-/-)Vh11 mice: a novel mouse model of CLL.
Zhong Y; Byrd JC
Blood; 2013 Oct; 122(16):2769-70. PubMed ID: 24136077
[No Abstract] [Full Text] [Related]
12. Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL).
Kasar S; Underbayev C; Hassan M; Ilev I; Degheidy H; Bauer S; Marti G; Lutz C; Raveche E; Batish M
PLoS One; 2016; 11(3):e0149331. PubMed ID: 26959643
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.
Huang D; Ovcharenko I
BMC Genomics; 2017 Mar; 18(1):236. PubMed ID: 28302063
[TBL] [Abstract][Full Text] [Related]
14. An intronic polymorphism of IRF4 gene influences gene transcription in vitro and shows a risk association with childhood acute lymphoblastic leukemia in males.
Do TN; Ucisik-Akkaya E; Davis CF; Morrison BA; Dorak MT
Biochim Biophys Acta; 2010 Feb; 1802(2):292-300. PubMed ID: 19897031
[TBL] [Abstract][Full Text] [Related]
15. IRF4 modulates the response to BCR activation in chronic lymphocytic leukemia regulating IKAROS and SYK.
Maffei R; Fiorcari S; Benatti S; Atene CG; Martinelli S; Zucchini P; Potenza L; Luppi M; Marasca R
Leukemia; 2021 May; 35(5):1330-1343. PubMed ID: 33623139
[TBL] [Abstract][Full Text] [Related]
16. Altered response to and production of TGF-beta by B cells from autoimmune NZB mice.
Douglas RS; Woo EY; Capocasale RJ; Tarshis AD; Nowell PC; Moore JS
Cell Immunol; 1997 Aug; 179(2):126-37. PubMed ID: 9268496
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia.
Kasar S; Underbayev C; Yuan Y; Hanlon M; Aly S; Khan H; Chang V; Batish M; Gavrilova T; Badiane F; Degheidy H; Marti G; Raveche E
Oncogene; 2014 Jun; 33(25):3307-15. PubMed ID: 23995789
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice.
Scaglione BJ; Salerno E; Gala K; Pan M; Langer JA; Mostowski HS; Bauer S; Marti G; Li Y; Tsiagbe VK; Raveche ES
J Autoimmun; 2009 Feb; 32(1):14-23. PubMed ID: 19022624
[TBL] [Abstract][Full Text] [Related]
19. H-2z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages.
Okamoto H; Nishimura H; Shinozaki A; Zhang D; Hirose S; Shirai T
Jpn J Cancer Res; 1993 Dec; 84(12):1273-8. PubMed ID: 7507474
[TBL] [Abstract][Full Text] [Related]
20. The correlation of telomerase and IL-10 with leukemia transformation in a mouse model of chronic lymphocytic leukemia (CLL).
Peng B; Zhang M; Sun R; Lin YC; Chong SY; Lai H; Stein D; Raveche ES
Leuk Res; 1998 Jun; 22(6):509-16. PubMed ID: 9678717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]